Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96 SEK | +3.00% | -1.84% | +6.67% |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 12-12-31 | |
Maria Ekdahl
DFI | Director of Finance/CFO | 51 | 22-09-18 |
Chief Operating Officer | 57 | 14-10-19 | |
Jonas Rastad
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Agneta Heierson
PRN | Corporate Officer/Principal | - | - |
Leif Gallo
LAW | General Counsel | 65 | - |
Michael Owens
AUD | Comptroller/Controller/Auditor | 68 | 15-12-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Margareta Hagman
BRD | Director/Board Member | 58 | 15-09-23 |
Chairman | 74 | 10-12-31 | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 17-05-03 |
Director/Board Member | 63 | 18-05-14 | |
Eva Idén
BRD | Director/Board Member | 58 | 17-05-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 10 | 453,283 | 0 | 0 | 88.04 % |
Stock B | 1 | 13,018,137 | 11,860,512 ( 91.11 %) | 0 |
Company contact information
Infant Bacterial Therapeutics AB
Bryggargatan 10
111 21, Stockholm
+46 7 62 19 37 38
http://www.ibtherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
|
Sector
1st Jan change | Capi. | |
---|---|---|
+6.67% | 121M | |
+16.93% | 79.38B | |
+9.32% | 8.74B | |
-14.24% | 4.94B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
+11.81% | 2.28B | |
-23.57% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B |
- Stock Market
- Equities
- IBT B Stock
- Company Infant Bacterial Therapeutics AB